Bladder Cancer Clinical Trial

A Genotype-Phenotype Urothelial Cancer Registry

Summary

This study is being done to create a registry to help us learn more about urinary and other cancers. This will let us look at large groups of people who do and do not have this kind of cancer.

The investigators will look at risk factors to learn more about how these impact cancer. The investigators will also look at genetic markers. These are genes that are found in a known place. They are often associated with a particular trait. If the gene changes in some way, it may predict cancer or response to treatment. The investigators will look for markers in your saliva.

This registry will help us develop better methods of:

Preventing these cancers. Diagnosing these cancers. Treating these cancers.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Urothelial Cancer Cases

Must be ≥ 18 years of age AND
Must have a diagnosis of urothelial cancer AND
Must be an English-speaker

Non-Cancer Control Group

Must be ≥ 18 years of age AND
Must not have cancer or a personal history of cancer, with the exception of skin cancer. AND
Must not be a blood relative of cases AND
Must not be a blood relative of another control AND
Must be an English-speaker

Family Member Control Group:

In select kindreds with a high prevalence of bladder cancer and/or very early onset bladder cancer, first- and second-degree family members of probands may be contacted by the MSKCC study team and invited to complete the questionnaire and submit a saliva sample.

Must be ≥ 18 years of age AND
Must be a blood relative of a case participant AND
Must be an English-speaker

Exclusion Criteria:

Have any condition, which in the opinion of the primary MSKCC clinician or investigators precludes their ability to provide informed consent.

Study is for people with:

Bladder Cancer

Estimated Enrollment:

3200

Study ID:

NCT00902590

Recruitment Status:

Recruiting

Sponsor:

Memorial Sloan Kettering Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 4 Locations for this study

See Locations Near You

Memorial Sloan Kettering Basking Ridge
Basking Ridge New Jersey, 07920, United States More Info
Dean Bajorin, MD
Contact
Memorial Sloan Kettering Commack
Commack New York, 11725, United States More Info
Dean Bajorin, MD
Contact
Memorial Sloan Kettering Cancer Center
New York New York, 10065, United States More Info
Dean Bajorin, MD
Contact
646-422-4333
Helena Furberg-Barnes, PhD
Contact
646-735-8118
Dean Bajorin, MD
Principal Investigator
Memorial Sloan Kettering Nassau
Uniondale New York, 11553, United States More Info
Dean Bajorin, MD
Contact
646-422-4333

How clear is this clinincal trial information?

Study is for people with:

Bladder Cancer

Estimated Enrollment:

3200

Study ID:

NCT00902590

Recruitment Status:

Recruiting

Sponsor:


Memorial Sloan Kettering Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.